Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model

Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model

Veure altres versions (1)

Although there is growing evidence for a role of excess intracellular cations, particularly calcium ions, in neuronal and glial cell injury in multiple sclerosis, as well as in non-inflammatory neurological conditions, the molecular mechanisms involved are not fully determined. We previously showed...

Descripció completa

Dades bibliogràfiques
Autors principals:	Vergo, S, Craner, M, Etzensperger, R, Attfield, K, Friese, M, Newcombe, J, Esiri, M, Fugger, L
Format:	Journal article
Idioma:	English
Publicat:	2011

Ítems similars

Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model.
per: Vergo, S, et al.
Publicat: (2011)

ASIC1 expression contributes to demyelination and axonal injury in EAE and MS
per: Vergo, S, et al.
Publicat: (2009)

Acid sensing ion channel 1 contributes to axonal degeneration in autoimmune CNS inflammation and provides a novel target for neuroprotection in multiple sclerosis
per: Craner, M, et al.
Publicat: (2008)

Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system.
per: Friese, M, et al.
Publicat: (2007)

The contribution of demyelination to axonal loss in multiple sclerosis
per: DeLuca, G, et al.
Publicat: (2006)

The contribution of demyelination to axonal loss in multiple sclerosis.
per: DeLuca, G, et al.
Publicat: (2006)

IL-21 and IL-21 receptor expression in lymphocytes and neurons in multiple sclerosis brain.
per: Tzartos, J, et al.
Publicat: (2011)

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis.
per: Tzartos, J, et al.
Publicat: (2008)

Axonal injury in reverse.
per: Craner, M, et al.
Publicat: (2011)

Evidence of axonal damage in human acute demyelinating diseases.
per: Ghosh, N, et al.
Publicat: (2004)

The immunology of multiple sclerosis
per: Attfield, KE, et al.
Publicat: (2022)

Misfiring in multiple sclerosis: cerebellar channelopathy, a potential novel target?
per: Craner, M, et al.
Publicat: (2012)

Interleukin-17 expression in multiple sclerosis
per: Tzartos, J, et al.
Publicat: (2006)

Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis.
per: Friese, M, et al.
Publicat: (2008)

The value of animal models for drug development in multiple sclerosis
per: Friese, M, et al.
Publicat: (2006)

The value of animal models for drug development in multiple sclerosis.
per: Friese, M, et al.
Publicat: (2006)

Extensive grey matter demyelination occurs in the spinal cord in multiple sclerosis
per: Gilmore, C, et al.
Publicat: (2005)

T cells and microglia as drivers of multiple sclerosis pathology.
per: Friese, M, et al.
Publicat: (2007)

T cells and microglia as drivers of multiple sclerosis pathology
per: Friese, M, et al.
Publicat: (2007)

Pathogenic CD8(+) T cells in multiple sclerosis.
per: Friese, M, et al.
Publicat: (2009)

TCR transgenic mice that shed light on immune and environmental regulators in multiple sclerosis.
per: Attfield, K, et al.
Publicat: (2013)

Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis.
per: Pomeroy, I, et al.
Publicat: (2005)

Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis.
per: Pomeroy, I, et al.
Publicat: (2005)

Dissection of the multiple sclerosis associated DR2 haplotype.
per: Etzensperger, R, et al.
Publicat: (2008)

Clinical and neurophysiological correlation in axonal and demyelinating polyneuropathy
per: Kamel Mahmoud Ali Hewedi, et al.
Publicat: (2020-06-01)

Protein co-expression with axonal injury in multiple sclerosis plaques.
per: Diaz-Sanchez, M, et al.
Publicat: (2006)

Axonal loss in the optic nerve and tract in multiple sclerosis
per: Esiri, M, et al.
Publicat: (2000)

Autoreactive CD8+ T cells in multiple sclerosis: A new target for therapy?
per: Friese, M, et al.
Publicat: (2005)

Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?
per: Friese, M, et al.
Publicat: (2005)

Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts.
per: DeLuca, G, et al.
Publicat: (2004)

Targeting ASIC1 in primary progressive multiple sclerosis: Evidence of neuroprotection with amiloride
per: Arun, T, et al.
Publicat: (2013)

Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.
per: Arun, T, et al.
Publicat: (2013)

Guillain-Barre syndrome: recovery patterns in demyelinating and axonal forms
per: D. A. Grishinа, et al.
Publicat: (2017-02-01)

Inflammation, demyelination, and axonal degeneration: Three aspects of the pathogenesis of multiple sclerosis revealed by campath-1H treatment
per: Coles, A, et al.
Publicat: (2003)

From genes to function: the next challenge to understanding multiple sclerosis
per: Fugger, L, et al.
Publicat: (2009)

From genes to function: the next challenge to understanding multiple sclerosis.
per: Fugger, L, et al.
Publicat: (2009)

Spinal cord gray matter demyelination in multiple sclerosis-a novel pattern of residual plaque morphology.
per: Gilmore, C, et al.
Publicat: (2006)

Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis.
per: Evangelou, N, et al.
Publicat: (2000)

Converging on the origins of axonal ion channel clustering.
per: Matthew N Rasband
Publicat: (2009-01-01)

Bridging the gap from genetic association to functional understanding: the next generation of mouse models of multiple sclerosis.
per: Attfield, K, et al.
Publicat: (2012)